Vitalist Inc. Proposes C$5M Equity, C$5M Debentures, and Credit Line Renewal

Vitalist Inc. (TSXV:VITA) has announced plans to raise capital and restructure its debt through three transactions, all pending TSX Venture Exchange approvals. The company is proposing a C$5.0 million equity placement at C$0.85 per share that includes warrants, along with an offering of up to C$5.0 million in 12% payment-in-kind convertible debentures. Concurrently, Vitalist renewed its C$12.0 million revolving credit facility through September 30, 2029.

The combined measures substantially extend the liquidity runway for Vitalist, supported by major shareholders who are anchoring roughly C$2.55 million of the debenture offering. However, the transactions introduce long-term risks for existing investors. The 12% interest rates on the debentures and credit facility, paid in kind, add to future debt balances. Furthermore, the accompanying warrants priced at C$1.00 and discounted debenture conversion terms create dilution risks for equity holders.

Investors will be watching for regulatory approval from the TSX Venture Exchange and the final closing of the equity and debenture offerings. Market participants will also monitor whether operational performance, revenue growth, or potential future public offerings can generate sufficient cash flow to manage the higher debt load and offset potential dilution. Shares of Vitalist Inc. traded down 5.56% to 0.68 CAD following the announcement.